Compare CVS Health Corp (CVS) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Palo Alto Networks Inc — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while Palo Alto Networks Inc trades at $400.3 (market cap $331.76B). The key difference: Palo Alto Networks Inc is far larger — about 2.9× CVS Health Corp's market cap, and CVS Health Corp pays a 3.02% dividend while Palo Alto Networks Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Palo Alto Networks Inc for 82 Days on average.
| CVS | PANW | |
|---|---|---|
Market Cap | $112.49B | $331.76B |
Volume | 8,467,392 | 3,886,927 |
Sector | Health | Technology |
52-Week High | $110.60 | $419.91 |
52-Week Low | $70.08 | $141.67 |
Typical Hold Time | 83 Days | 82 Days |
Enterprise Value | $174.83B | $331.19B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Palo Alto Networks (PANW) trades at $398.50, down 5.1% today but remains near its 52-week high. The stock shows strong technical momentum with bullish moving averages and positive analyst sentiment (72% buy ratings). Recent earnings beats and robust revenue growth to $9.22B in 2025 highlight fundamental strength, though valuation metrics appear elevated with P/E at 1,013.93 and P/S at 26.99. The company's AI-driven security platform and continuous defense services are driving market optimism.
Outlook remains positive given cybersecurity demand and AI integration, but premium valuation and rising costs pose risks. Revenue growth acceleration to $11.5B projected for 2026 supports bullish case, while net margin compression to 2.67% warrants monitoring. Analyst consensus target of $398.70 suggests limited near-term upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
